Growth Factors as Therapeutics for Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
47-59
Author(s):
Nigel A. Calcutt, Corinne G. Jolivalt and Paul Fernyhough
Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Journal:
Current Drug Targets
Volume:
9
Page:
60-67
Author(s):
Norman E. Cameron and Mary A. Cotter
Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
68-76
Author(s):
Rodica Pop-Busui, Aaron P. Kellogg and Hsinlin Thomas Cheng
The Potential Role of Angiotensin Converting Enzyme and Vasopeptidase Inhibitors in the Treatment of Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
77-84
Author(s):
Mark A. Yorek
Metabotropic Glutamate Receptors (mGluRs) and Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
85-93
Author(s):
James W. Russell, Muragundla Anjaneyulu and Alison Berent-Spillson
The Antioxidant Response as a Drug Target in Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
94-100
Author(s):
Andrea M. Vincent, James L. Edwards, Mahdieh Sadidi and Eva L. Feldman
Pharmacologic Intervention in Axonal Excitability: In Vivo Assessment of Nodal Persistent Sodium Currents in Human Neuropathies
Journal:
Current Molecular Pharmacology
Volume:
1
Page:
61-67
Author(s):
Satoshi Kuwabara and Sonoko Misawa
Weight Loss in Older Persons: New Therapeutic Approaches
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3637-3647
Author(s):
John E. Morley
Editorial [ Receptor for Advanced Glycation Endproducts (RAGE): Coming Full Circle in Unraveling the Pathogenesis of Chronic Disease Guest Editor: Ann Marie Schmidt ]
Journal:
Current Molecular Medicine
Volume:
7
Page:
697-698
Author(s):
Ann Marie Schmidt
RAGE, Diabetes, and the Nervous System
Journal:
Current Molecular Medicine
Volume:
7
Page:
766-776
Author(s):
Cory Toth, Jose Martinez and Douglas W. Zochodne